首页> 外文期刊>Urology >Is a second injection of vasoactive medication necessary during color duplex doppler evaluation of young patients with veno-occlusive erectile dysfunction?
【24h】

Is a second injection of vasoactive medication necessary during color duplex doppler evaluation of young patients with veno-occlusive erectile dysfunction?

机译:对年轻的静脉闭塞性勃起功能障碍患者进行彩超检查时是否需要第二次注射血管活性药物?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To assess the contribution of a second injection of vasoactive medication into the corpus cavernosum during the duplex Doppler study for evaluation of young patients with vasculogenic erectile dysfunction (ED). METHODS: Thirty-five patients, 23 to 50 years old (median age 43), clinically diagnosed as having veno-occlusive ED underwent a color duplex Doppler study. The peak systolic velocity, end-diastolic velocity, resistance index, and arterial diameter measurements were obtained from both cavernosal arteries before and 2, 5, 10, and 20 minutes after an intracavernous injection of a vasoactive drug. All patients were reinjected with similar doses of the same medication, and all measurements were repeated. The erection quality was estimated 20 minutes after each injection. RESULTS: The peak systolic velocity after the second injection was significantly higher statistically than after the first injection (P <0.02). No differences in end-diastolic velocity, resistance index, arterial diameter, or the evaluated side between the first and second injections were found. CONCLUSIONS: A single injection of vasoactive drugs can provide sufficient information on the arterial and veno-occlusive mechanism during color duplex Doppler evaluation of young patients with vasculogenic ED without compromising the quality of the evaluation. Limiting the number of injections to only one may prevent adverse reactions caused by the second injection and reduce the cost and duration of this test.
机译:目的:评估在双重多普勒研究期间评估血管生成性勃起功能障碍(ED)年轻患者的第二次血管活性药物对海绵体的贡献。方法:对35例年龄在23至50岁(中位年龄为43岁)的临床诊断为静脉阻塞性ED的患者进行了彩色多普勒研究。收缩压峰值速度,舒张末期速度,阻力指数和动脉直径的测量值是在海绵内注射血管活性药物之前,2、5、10和20分钟后从两个海绵体动脉获得的。所有患者均被注射相同剂量的相同药物,并重复所有测量。每次注射后20分钟估计勃起质量。结果:第二次注射后的收缩期峰值速度在统计学上显着高于第一次注射后(P <0.02)。在第一次和第二次注射之间没有发现舒张末期速度,阻力指数,动脉直径或评估侧的差异。结论:单次注射血管活性药物可在彩色多普勒评估年轻血管生成性ED患者的过程中提供足够的动脉和静脉闭塞机制信息。将注射次数限制为一次只能防止第二次注射引起的不良反应,并减少此测试的成本和持续时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号